Eliminating Inappropriate Antipsychotic Medication Use
Webinar "Eliminating Inappropriate Anti-psychotic Medication Use"
- Develop an understanding of the Anti-psychotic medication quality measure
- Identify the significance of using Critical Thinking related to Anti-psychotic medication use and how to eliminate off-label use in residents with dementia
- Identify the significance of Engaging the Resident and/or Representative in Decision-Making.
Understanding the long stay Anti-psychotic quality measure “Percent of long stay residents who received an anti-psychotic medication”; and how the measure is calculated is beneficial to eliminating inappropriate medication use and thus improving residents’ quality of care. Residents receiving inappropriate anti-psychotic medication must have the medication eliminated. Resident should only be given medication if clinically indicated as necessary to treat a specific diagnosis, and target symptoms as diagnosed and documented in the medical record. Residents that are fittingly prescribed and receive anti-psychotic medications must also receive gradual dose reductions and behavioral interventions, unless clinically contraindicated, in an effort discontinue the drugs. To ensure prudent use of psycho-pharmacological medications, residents (to the extent possible) or their representatives should be actively engaged in the discussion of potential approaches to address recognized behavioral symptoms.
Review the organizations anti-psychotic quality measure data; review residents that trigger the quality measure; review the off-label use for the medication, discuss an area targeted for improvement of the measure based on the CASPER, QAPI self-assessment data, and policy and procedure practice (i.e. QM, interdepartmental communication practice, staff stability issues, consistent assignment, prescribing practice etc.); develop a strategy and timeline to eliminate inappropriate medication use.